# Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

> **NCT07131956** · — · RECRUITING · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Cancer (Diagnosis)
- Prostate Cancer Patients Who Have Brachytherapy Seed Implant
- Prostate Cancer Patients Treated by Radiotherapy
- Prostate Cancer Recurrent

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07131956
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07131956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07131956, "Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07131956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*